LuminoDx is a clinical-stage precision diagnostics company specializing in liquid biopsy solutions for liver disease testing and monitoring. Our lead product, HepatoTrack™, is a CLIA-validated, noninvasive assay for detecting liver allograft rejection, designed to reduce biopsy dependence and improve post-transplant outcomes. Our pipeline includes a miRNA-based MASH assay for patient stratification and therapy response monitoring. We are currently raising a Series A to accelerate commercialization and are actively seeking global partners to support international expansion.
Address
San DiegoCalifornia
United States
